Načítá se...
Metformin may reduce oral cancer risk in patients with type 2 diabetes
BACKGROUND: Whether metformin use may affect the risk of oral cancer required further investigation. METHODS: The reimbursement database of the National Health Insurance in Taiwan was used. Patients with type 2 diabetes mellitus at an onset age of 25-74 years during 1999-2005 and newly treated with...
Uloženo v:
| Vydáno v: | Oncotarget |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Impact Journals LLC
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4811512/ https://ncbi.nlm.nih.gov/pubmed/26683519 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|